Seng and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Seng (ginseng, panax), especially for people who are female, 60+ old, also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Weight loss when taking Seng. It is created by eHealthMe based on reports of 1,057 people who have side effects when taking Seng from the FDA, and is updated regularly.

What is Seng?

Seng has active ingredients of ginseng, panax. eHealthMe is studying from 1,152 Seng users. Check the latest studies of Seng.

What is Weight loss?

Weight loss is found to be associated with 1,444 drugs and 2,297 conditions by eHealthMe. Check the latest studies of Weight loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 14, 2026

1,057 people reported to have side effects when taking Seng.
Among them, 18 people (1.7%) have Weight loss.

Among these 18 people:

What is the gender of people who have Weight loss when taking Seng? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Weight loss when taking Seng? *

What are other drugs people take besides Seng? *

What are other side effects people have besides Weight loss? *

Joint Range Of Motion Decreased (disease of joint movement): 17 people, 94.44%
Joint Pain: 17 people, 94.44%
Weakness: 17 people, 94.44%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 17 people, 94.44%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 17 people, 94.44%
Synovitis (inflammation of the synovial membrane): 17 people, 94.44%
Arthropathy: 17 people, 94.44%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 17 people, 94.44%
Hepatic Enzyme Increased: 17 people, 94.44%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 17 people, 94.44%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 50.00%
Pain: 8 people, 44.44%
Stress And Anxiety: 2 people, 11.11%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 11.11%
Indigestion: 2 people, 11.11%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 11.11%
Migraine (headache): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Seng and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seng:

Seng (1,152 reports)

Weight loss treatments and more:

Weight loss (62,432 reports)

Browse all side effects of Seng:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Weight loss (1,444 drugs)

Browse all the conditions that are associated with Weight loss:

Weight loss (2,297 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ginseng, panax (the active ingredients of Seng) and Seng (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.